ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC33494-1mg |
|
39967-60-7 |
Deoxypseudouridine
|
0 | C9H12N2O5 | |
GC33494-10mM(1mLinDMSO) |
|
39967-60-7 |
Deoxypseudouridine
|
0 | C9H12N2O5 | |
GC33493-50mg |
|
53213-82-4 |
3,3’-Dihexyloxacarbocyanine iodide (DiOC6(3) iodide)
|
0 | C29H37IN2O2 | |
GC33492-25mg |
|
1435786-04-1 |
Rapastinel Trifluoroacetate (GLYX-13 Trifluoroacetate)
|
0 | C20H32F3N5O8 | |
GC33492-10mg |
|
1435786-04-1 |
Rapastinel Trifluoroacetate (GLYX-13 Trifluoroacetate)
|
0 | C20H32F3N5O8 | |
GC33492-5mg |
|
1435786-04-1 |
Rapastinel Trifluoroacetate (GLYX-13 Trifluoroacetate)
|
0 | C20H32F3N5O8 | |
GC33492-1mg |
|
1435786-04-1 |
Rapastinel Trifluoroacetate (GLYX-13 Trifluoroacetate)
|
0 | C20H32F3N5O8 | |
GC33492-10mM(1mLinDMSO) |
|
1435786-04-1 |
Rapastinel Trifluoroacetate (GLYX-13 Trifluoroacetate)
|
0 | C20H32F3N5O8 | |
GC33491-10mg |
|
1189904-01-5 |
Acetazolamide D3
|
0 | C4H3D3N4O3S2 | |
GC33491-5mg |
|
1189904-01-5 |
Acetazolamide D3
|
0 | C4H3D3N4O3S2 | |
GC33491-1mg |
|
1189904-01-5 |
Acetazolamide D3
|
0 | C4H3D3N4O3S2 | |
GC33490-500mg |
|
85-73-4 |
Phthalylsulfathiazole (N4-Phthalylsulfathiazole)
|
0 | C17H13N3O5S2 | |
GC33490-10mM(1mLinDMSO) |
|
85-73-4 |
Phthalylsulfathiazole (N4-Phthalylsulfathiazole)
|
0 | C17H13N3O5S2 | |
GC33489-50mg |
|
79955-27-4 |
5-CFDA (5-Carboxyfluorescein diacetate)
|
0 | C25H16O9 | |
GC33489-10mM(1mLinDMSO) |
|
79955-27-4 |
5-CFDA (5-Carboxyfluorescein diacetate)
|
0 | C25H16O9 | |
GC33488-10mg |
|
88105-29-7 |
Notoginsenoside Fe (Notoginseng triterpenes)
|
0 | C47H80O17 | |
GC33488-5mg |
|
88105-29-7 |
Notoginsenoside Fe (Notoginseng triterpenes)
|
0 | C47H80O17 | |
GC33487-100mg |
|
6 |
6-CFDA (6-Carboxyfluorescein diacetate)
|
0 | C25H16O9 | |
GC33487-50mg |
|
6 |
6-CFDA (6-Carboxyfluorescein diacetate)
|
0 | C25H16O9 | |
GC33487-10mg |
|
6 |
6-CFDA (6-Carboxyfluorescein diacetate)
|
0 | C25H16O9 | |